Incytevs.Moderna
INCY vs MRNA · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Moderna is about 1.2× larger than Incyte by market cap; year to date, Moderna leads (+131.5% vs +18.2%).
Side by side
| INCY | MRNA | |
|---|---|---|
| Market cap | $23.1B | $27.2B |
| Price | $116.71 | $68.27 |
| Today | −1.5% | −10.8% |
| Return YTD | +18.2% | +131.5% |
| Return 1Y | +65.9% | +99.2% |
| P/E | 16.1 | — |
| P/S | 4.3 | 12.2 |
| P/B | 4.1 | 3.7 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
ModernaMRNA
American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.
Full MRNA profile →More comparisons in Biotech & innovation
See where INCY and MRNA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →